Ali Rezaei Mokarram

427 citations
15 papers · 307 indexed · h-index 9
Topics
Advanced Drug Delivery Systems (6 papers)RNA Interference and Gene Delivery (3 papers)SARS-CoV-2 and COVID-19 Research (2 papers)
Journals
SHILAP Revista de lepidopterologíaFrontiers in ImmunologyNanoscale Research Letters
Partner nations
IranUnited States

In The Last Decade

Ali Rezaei Mokarram

15 papers receiving 293 citations

Peers

Ali Rezaei Mokarram
Comparison fields: 5 of 75
  • Molecular Biology 110
  • Pharmaceutical Science 79
  • Biomaterials 54
  • Public Health, Environmental and Occupational Health 48
  • Infectious Diseases 42
Replace Riham M. El‐Moslemany with:
Riham M. El‐Moslemany Egypt
María Julia Altube Argentina
Hongwu Sun China
R. Espada Spain
Ana Paula Perez Argentina
Maria Federica Giardi Italy
Sixiang Sai China
Mushir M. Ali India
Chetan G. Shinde India
Cristina de Castro Spadari Brazil
Ali Rezaei Mokarram relative to Riham M. El‐Moslemany Egypt Riham M. El‐Moslemany's profile →
Citations per field
00.5×1.5×1.9×
Riham M. El‐Moslemany · 1×
Citations per year

Countries citing papers authored by Ali Rezaei Mokarram

Since Specialization
Citations

This map shows the geographic impact of Ali Rezaei Mokarram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Rezaei Mokarram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Rezaei Mokarram more than expected).

Fields of papers citing papers by Ali Rezaei Mokarram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Rezaei Mokarram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Rezaei Mokarram. The network helps show where Ali Rezaei Mokarram may publish in the future.

Co-authorship network of co-authors of Ali Rezaei Mokarram

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Rezaei Mokarram. A scholar is included among the top collaborators of Ali Rezaei Mokarram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Rezaei Mokarram. Ali Rezaei Mokarram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 2
2 27
3 13
4 6
5 21
6 44
7 3
8 97
9 8
10 20
11 15
12
Preparation and in-vitro evaluation of indomethacin nanoparticles.
23
13 4
14 19
15 5

About Ali Rezaei Mokarram

Ali Rezaei Mokarram is a scholar working on Pharmaceutical Science, Microbiology and Infectious Diseases, having authored 15 papers that have together received 307 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (6 papers), RNA Interference and Gene Delivery (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Pharmaceutical Science (79 citations), Biomaterials (54 citations) and Infectious Diseases (42 citations). Ali Rezaei Mokarram has collaborated with scholars based in Iran and United States. Frequent co-authors include Roghayeh Abbasalipourkabir, Mohammad Taghi Goodarzi, Massoud Saidijam, Elham Bahreini, Khosrow Aghaiypour, Ali Es‐haghi, Majid Soleimani, Marı́a José Alonso, Mosadegh Keshavarz and Seyyed Mahmoud Ebrahimi. Their work appears in journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Nanoscale Research Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026